Graig Suvannavejh
Stock Analyst at Mizuho
(3.64)
# 823
Out of 5,042 analysts
161
Total ratings
49.59%
Success rate
6.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Graig Suvannavejh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings | Maintains: Outperform | $50 → $35 | $29.41 | +19.01% | 19 | Sep 25, 2025 | |
| IDYA IDEAYA Biosciences | Maintains: Outperform | $43 → $44 | $31.39 | +40.17% | 2 | Sep 12, 2025 | |
| BTAI BioXcel Therapeutics | Maintains: Neutral | $2 → $4 | $1.95 | +105.66% | 9 | Sep 12, 2025 | |
| KALA KALA BIO | Initiates: Outperform | $30 | $0.78 | +3,746.15% | 1 | Sep 8, 2025 | |
| INSM Insmed | Maintains: Outperform | $130 → $165 | $183.18 | -9.92% | 11 | Aug 13, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Neutral | $21 → $22 | $20.40 | +7.84% | 10 | Aug 4, 2025 | |
| ALEC Alector | Upgrades: Outperform | $2.5 → $3.5 | $1.42 | +147.35% | 5 | Jul 28, 2025 | |
| NMRA Neumora Therapeutics | Maintains: Outperform | $4 → $5 | $2.95 | +69.49% | 2 | Jul 16, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Outperform | $16 → $12 | $4.29 | +179.72% | 5 | Jun 26, 2025 | |
| IMRX Immuneering | Maintains: Outperform | $8 → $10 | $6.59 | +51.75% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $11 | $7.93 | +38.71% | 3 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $26 | $12.76 | +103.76% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $8 | $13.47 | -40.61% | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $33 | $32.07 | +2.90% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $212 → $216 | $134.33 | +60.80% | 21 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 → $7.6 | $1.53 | +396.73% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $74 | $12.02 | +515.64% | 1 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $50 → $5 | $4.05 | +23.46% | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $44 → $49 | $65.34 | -25.01% | 6 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $9.85 | +62.44% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $10 | $15.49 | -35.42% | 5 | Nov 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $1 | $5.47 | -81.72% | 5 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $113.04 | -69.04% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8 | $17.89 | -55.28% | 6 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $57 | $60.79 | -6.23% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $5 | $33.69 | -85.16% | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $9.09 | +274.04% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $28 | $6.54 | +328.13% | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $31 | $18.15 | +70.80% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $380 | $23.19 | +1,538.64% | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $4.75 | $1.90 | +150.00% | 1 | Nov 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $24.61 | +46.28% | 2 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $31.17 | - | 1 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $37 | $1.56 | +2,271.79% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $128 | $138.07 | -7.29% | 1 | Sep 14, 2020 |
Harmony Biosciences Holdings
Sep 25, 2025
Maintains: Outperform
Price Target: $50 → $35
Current: $29.41
Upside: +19.01%
IDEAYA Biosciences
Sep 12, 2025
Maintains: Outperform
Price Target: $43 → $44
Current: $31.39
Upside: +40.17%
BioXcel Therapeutics
Sep 12, 2025
Maintains: Neutral
Price Target: $2 → $4
Current: $1.95
Upside: +105.66%
KALA BIO
Sep 8, 2025
Initiates: Outperform
Price Target: $30
Current: $0.78
Upside: +3,746.15%
Insmed
Aug 13, 2025
Maintains: Outperform
Price Target: $130 → $165
Current: $183.18
Upside: -9.92%
Apellis Pharmaceuticals
Aug 4, 2025
Maintains: Neutral
Price Target: $21 → $22
Current: $20.40
Upside: +7.84%
Alector
Jul 28, 2025
Upgrades: Outperform
Price Target: $2.5 → $3.5
Current: $1.42
Upside: +147.35%
Neumora Therapeutics
Jul 16, 2025
Maintains: Outperform
Price Target: $4 → $5
Current: $2.95
Upside: +69.49%
Adverum Biotechnologies
Jun 26, 2025
Maintains: Outperform
Price Target: $16 → $12
Current: $4.29
Upside: +179.72%
Immuneering
Jun 18, 2025
Maintains: Outperform
Price Target: $8 → $10
Current: $6.59
Upside: +51.75%
May 20, 2025
Maintains: Outperform
Price Target: $12 → $11
Current: $7.93
Upside: +38.71%
May 16, 2025
Maintains: Outperform
Price Target: $30 → $26
Current: $12.76
Upside: +103.76%
May 14, 2025
Maintains: Outperform
Price Target: $7 → $8
Current: $13.47
Upside: -40.61%
Apr 7, 2025
Maintains: Neutral
Price Target: $38 → $33
Current: $32.07
Upside: +2.90%
Mar 27, 2025
Maintains: Outperform
Price Target: $212 → $216
Current: $134.33
Upside: +60.80%
Nov 18, 2024
Upgrades: Buy
Price Target: $7 → $7.6
Current: $1.53
Upside: +396.73%
Sep 20, 2024
Reiterates: Outperform
Price Target: $74
Current: $12.02
Upside: +515.64%
Sep 19, 2024
Downgrades: Neutral
Price Target: $50 → $5
Current: $4.05
Upside: +23.46%
Jul 22, 2024
Maintains: Neutral
Price Target: $44 → $49
Current: $65.34
Upside: -25.01%
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $9.85
Upside: +62.44%
Nov 27, 2023
Maintains: Buy
Price Target: $17 → $10
Current: $15.49
Upside: -35.42%
Jun 5, 2023
Downgrades: Neutral
Price Target: $17 → $1
Current: $5.47
Upside: -81.72%
Nov 10, 2022
Maintains: Buy
Price Target: $31 → $35
Current: $113.04
Upside: -69.04%
Nov 10, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $17.89
Upside: -55.28%
May 24, 2022
Maintains: Buy
Price Target: $71 → $57
Current: $60.79
Upside: -6.23%
Apr 19, 2022
Maintains: Sell
Price Target: $8 → $5
Current: $33.69
Upside: -85.16%
Jun 1, 2021
Initiates: Buy
Price Target: $34
Current: $9.09
Upside: +274.04%
Apr 20, 2021
Initiates: Neutral
Price Target: $28
Current: $6.54
Upside: +328.13%
Apr 19, 2021
Initiates: Neutral
Price Target: $31
Current: $18.15
Upside: +70.80%
Mar 2, 2021
Initiates: Sell
Price Target: $380
Current: $23.19
Upside: +1,538.64%
Nov 24, 2020
Initiates: Neutral
Price Target: $4.75
Current: $1.90
Upside: +150.00%
Nov 9, 2020
Upgrades: Buy
Price Target: $36
Current: $24.61
Upside: +46.28%
Oct 21, 2020
Downgrades: Sell
Price Target: n/a
Current: $31.17
Upside: -
Oct 20, 2020
Initiates: Neutral
Price Target: $37
Current: $1.56
Upside: +2,271.79%
Sep 14, 2020
Downgrades: Sell
Price Target: $128
Current: $138.07
Upside: -7.29%